Tassos Gianakakos

2014

In 2014, Tassos Gianakakos earned a total compensation of $488.9K as President, Chief Executive Officer and Director at MyoKardia.

Compensation breakdown

Non-Equity Incentive Plan$112,875
Salary$375,000
Other$500
Total$488,875

Gianakakos received $375K in salary, accounting for 77% of the total pay in 2014.

Gianakakos also received $112.9K in non-equity incentive plan and $500 in other compensation.

Rankings

In 2014, Tassos Gianakakos' compensation ranked 10,337th out of 13,032 executives tracked by ExecPay. In other words, Gianakakos earned more than 20.7% of executives.

ClassificationRankingPercentile
All
10,337
out of 13,032
21st
Division
Manufacturing
3,928
out of 4,966
21st
Major group
Chemicals And Allied Products
1,349
out of 1,686
20th
Industry group
Drugs
1,079
out of 1,365
21st
Industry
Pharmaceutical Preparations
830
out of 1,043
20th
Source: SEC filing on April 28, 2016.

Gianakakos' colleagues

We found one more compensation record of an executive who worked with Tassos Gianakakos at MyoKardia in 2014.

2014

Robert McDowell

MyoKardia

Senior Vice President of Drug Discovery

News

You may also like